[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350226-105":59,"doc-detail-350226-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mitochondrial-biology-and-immune-crosstalk-in-breast-cancer-therapeutic-opportunities-and-challenges","Mitochondrial biology and immune crosstalk in breast cancer: therapeutic opportunities and challenges","","Mitochondria act as central regulators of breast cancer progression and therapeutic response beyond energy metabolism, integrating redox balance, regulated cell death, metabolic plasticity, and immune signaling. This review explains how mitochondrial metabolism, dynamics, stress responses, and quality-control pathways influence tumor heterogeneity, immune evasion, and treatment outcomes across tumor, immune, and stromal compartments. It details subtype-specific mitochondrial programs, including OXPHOS, fatty acid oxidation, glutaminolysis, lactate and mtDAMP signaling, and discusses apoptosis, ferroptosis, cuproptosis, and pyroptosis. Mitochondria-targeted strategies show translational potential but face constraints from metabolic heterogeneity, adaptive rewiring, immune-cell liabilities, and limited biomarkers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mitochondrial-biology-and-immune-crosstalk-in-breast-cancer-therapeutic-opportunities-and-challenges/350226/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mitochondrial-biology-and-immune-crosstalk-in-breast-cancer-therapeutic-opportunities-and-challenges/350226.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do mitochondria influence breast cancer progression and therapy response?","Question",{"text":112,"@type":113},"Mitochondria regulate progression and response by integrating redox balance, regulated cell death, metabolic plasticity, and immune signaling, not just ATP production.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role do mitochondrial programs play across breast cancer subtypes?",{"text":117,"@type":113},"Subtype-specific mitochondrial programs affect oxidative phosphorylation, fatty acid oxidation, glutaminolysis, lactate accumulation, and mtDAMP signaling, contributing to immune suppression and therapeutic resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"Which mitochondrial-regulated cell death pathways are discussed as therapeutic opportunities?",{"text":121,"@type":113},"The review discusses apoptosis, ferroptosis, cuproptosis, and pyroptosis, highlighting both opportunities and unresolved limitations for therapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350226,1790400652,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","TYPE Review  \nPUBLISHED 22 April 2026  \nDOI 10.3389/fimmu.2026.1715998  \nOPEN ACCESS  \nEDITED BY  \nHamid Mirzaei,  \nUniversity of Texas MD Anderson Cancer Center, United States  \nREVIEWED BY  \nJonathan Barra,  \nIcahn School of Medicine at Mount Sinai, United States  \nDrew Wilfahrt,  \nUniversity of Pittsburgh, United States  \n*CORRESPONDENCE  \nYingjie Guo  \n[yingjie.guo@arcinstitute.org](yingjie.guo@arcinstitute.org)  \nRECEIVED 30 September 2025  \nREVISED 01 April 2026  \nACCEPTED 06 April 2026  \nPUBLISHED 22 April 2026  \nCITATION  \nZeng Y and Guo Y (2026) Mitochondrial biology and immune crosstalk in breast cancer: therapeutic opportunities and challenges.  \nFront. Immunol. 17:1715998 .  \ndoi: 10.3389/fimmu.2026.1715998  \nCOPYRIGHT  \n© 2026 Zeng and Guo. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMitochondrial biology and immune crosstalk in breast cancer: therapeutic opportunities and challenges  \nYulin Zeng 1 and Yingjie Guo 2*  \n1School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China, 2Arc Institute, Palo Alto, CA, United States  \nMitochondria are central regulators of breast cancer progression and therapy response, acting beyond energy metabolism to integrate redox balance, regulated cell death, metabolic plasticity, and immune signaling. This review summarizes how mitochondrial metabolism, dynamics, stress signaling, and qualitycontrol pathways shape tumor heterogeneity, immune evasion, and treatment outcomes across tumor, immune, and stromal compartments. In breast cancer, subtype-speciﬁc mitochondrial programs inﬂuence oxidative phosphorylation, fatty acid oxidation, glutaminolysis, lactate accumulation, and mtDAMP signaling, thereby contributing to immune suppression and therapeutic resistance. We further discuss how mitochondrial regulation of apoptosis, ferroptosis, cuproptosis, and pyroptosis reveals both therapeutic opportunities and unresolved limitations. Although mitochondria-targeted strategies show translational promise, their clinical application remains constrained by metabolic heterogeneity, adaptive rewiring, immune-cell liability, and insufﬁcient biomarkers. Overall, mitochondria represent a context-dependent therapeutic axis in breast cancer.  \nKEYWORDS  \nbreast cancer, immune crosstalk, immune evasion, mitochondria, tumor microenvironment  \n1 Introduction  \nBreast cancer remains a leading cause of cancer-related mortality worldwide, and its management is hindered not only by genomic heterogeneity but also by profound metabolic and immunological diversity.  \nMounting evidence indicates that mitochondria function far beyond ATP production, acting as dynamic hubs that integrate bioenergetics, biosynthesis, cell death regulation, and immune signaling. In breast cancer, mitochondrial remodeling—encompassing oxidative phosphorylation (OXPHOS) reprogramming, reactive oxygen species (ROS) ﬂux, mitochondrial DNA (mtDNA) release, and quality control pathways—directly shapes both tumor cell ﬁtness and immune cell function within the tumor microenvironment (TME) . In this review, we examine mitochondria through a dual-focus lens: as metabolic engines that sustain tumor progression and as immunomodulatory platforms that inﬂuenceantitumor or protumor immunity. By integrating recent advances in mitochondrial metabolism, dynamics, stress signaling, and quality control with immune evasion and  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nresistance mechanisms, we outline a framework linking mitochondrial biology to drug response, immune checkpoint efﬁcacy, and therapeutic vulnerab","cbCailTHXM6ggayu","https://ap.wps.com/l/cbCailTHXM6ggayu","pdf",1971758,14,"English","# Introduction\n## Subtype-specific metabolic heterogeneity and immune relevance\n# Mitochondrial metabolic programs and immune consequences in breast cancer","[{\"question\":\"How do mitochondria influence breast cancer progression and therapy response?\",\"answer\":\"Mitochondria regulate progression and response by integrating redox balance, regulated cell death, metabolic plasticity, and immune signaling, not just ATP production.\"},{\"question\":\"What role do mitochondrial programs play across breast cancer subtypes?\",\"answer\":\"Subtype-specific mitochondrial programs affect oxidative phosphorylation, fatty acid oxidation, glutaminolysis, lactate accumulation, and mtDAMP signaling, contributing to immune suppression and therapeutic resistance.\"},{\"question\":\"Which mitochondrial-regulated cell death pathways are discussed as therapeutic opportunities?\",\"answer\":\"The review discusses apoptosis, ferroptosis, cuproptosis, and pyroptosis, highlighting both opportunities and unresolved limitations for therapy.\"}]","Mitochondrial biology and immune crosstalk in breast cancer: therapeutic opportunities and challenges | PDF",1790087929,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/320b5d8b2114d79c2dbb10b48d05b5ff.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b907e6af7714479fc6327cd074a7ef2d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06b96cdf71b68cc82d13e7037b42d5bc.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33248b8e35ff1668ebdb0da430af079c.webp",980,1385]